Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Purinergic receptors are a family of plasma membrane proteins that mediate the effects of extracellular purines such as adenosine and ATP. They are divided into three main categories: P1 receptors (adenosine receptors), P2X receptors (ATP-gated ion channels), and P2Y receptors (nucleotide-activated GPCRs). These receptors are widely distributed and involved in various physiological and pathological processes, including neurotransmission, immune responses, inflammation, and cancer. Dysregulation of purinergic signaling is implicated in numerous diseases, making these receptors potential therapeutic targets.
Modulation of purinergic signaling pathways through agonism or antagonism of specific receptor subtypes.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purinergic Receptors.